Skip to main content
NCBI home page
California Medicine logoLink to California Medicine
. 1969 Jan;110(1):43–60.

Current status of the management of patients with endocrine-sensitive tumors. I. Introduction and carcinoma of the breast.

L G Crowley
PMCID: PMC1503404  PMID: 4883505

Full text

PDF
43

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AHREN K., HAMBERGER L. Direct action of testosterone propionate on the rat mammary gland. Acta Endocrinol (Copenh) 1962 Jun;40:265–276. doi: 10.1530/acta.0.0400265. [DOI] [PubMed] [Google Scholar]
  2. ATKINS H. J., FALCONER M. A., HAYWARD J. L., MACLEAN K. S., SCHURR P. H., ARMITAGE P. Adrenalectomy and hypophysectomy for advanced cancer of the breast. Lancet. 1960 May 28;1(7135):1148–1153. doi: 10.1016/s0140-6736(60)91039-4. [DOI] [PubMed] [Google Scholar]
  3. ATKINS H. A comparison of adrenalectomy and oophorectomy with hypopthsectomy in the treatment of advanced cancer of the breast. Proc R Soc Med. 1960 Aug;53:638–641. doi: 10.1177/003591576005300813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BARON D. N., GURLING K. J., SMITH E. R. The effect of hypophysectomy in advanced carcinoma of the breast. Br J Surg. 1958 May;45(194):593–606. doi: 10.1002/bjs.18004519407. [DOI] [PubMed] [Google Scholar]
  5. BLOCK G. E., LAMPE I., VIAL A. B., COLLER F. A. Therapeutic castration for advanced mammary cancer. Surgery. 1960 Jun;47:877–884. [PubMed] [Google Scholar]
  6. BROWN J. B. A chemical method for the determination of oestriol, oestrone and oestradiol in human urine. Biochem J. 1955 Jun;60(2):185–193. doi: 10.1042/bj0600185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BROWN J. B., BULBROOK R. D., GREENWOOD F. C. An additional purification step for a method for estimating oestriol, oestrone and oestradiol-17 beta in human urine. J Endocrinol. 1957 Nov;16(1):49–56. doi: 10.1677/joe.0.0160049. [DOI] [PubMed] [Google Scholar]
  8. BULBROOK R. D., GREENWOOD F. C., HADFIELD G. J., SCOWEN E. F. Adrenalectomy in breast cancer; an attempt to correlate clinical results with oestrogen production. Br Med J. 1958 Jul 5;2(5087):12–15. doi: 10.1136/bmj.2.5087.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. BULBROOK R. D., GREENWOOD F. C., HADFIELD G. J., SCOWEN E. F. Hypophysectomy in breast cancer; an attempt to correlate clinical results with oestrogen production. Br Med J. 1958 Jul 5;2(5087):15–18. doi: 10.1136/bmj.2.5087.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. BULBROOK R. D., GREENWOOD F. C., HAYWARD J. L. Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone. Lancet. 1960 May 28;1(7135):1154–1157. doi: 10.1016/s0140-6736(60)91040-0. [DOI] [PubMed] [Google Scholar]
  11. BULBROOK R. D., HAYWARD J. L., SPICER C. C., THOMAS B. S. A comparison between the urinary steroid excretion of normal women and women with advanced breast cancer. Lancet. 1962 Dec 15;2(7268):1235–1237. doi: 10.1016/s0140-6736(62)92811-8. [DOI] [PubMed] [Google Scholar]
  12. BULBROOK R. D., HAYWARD J. L., SPICER C. C., THOMAS B. S. Abnormal excretion of urinary steroids by women with early breast cancer. Lancet. 1962 Dec 15;2(7268):1238–1240. doi: 10.1016/s0140-6736(62)92812-x. [DOI] [PubMed] [Google Scholar]
  13. BYRON R. L., Jr, YONEMOTO R. H., BASHORE R., BIERMAN H. R., CRONEMILLER P., MASTERS H. Bilateral adrenalectomy in advanced breast cancer. Surgery. 1962 Nov;52:725–732. [PubMed] [Google Scholar]
  14. Bulbrook R. D., Hayward J. L. Abnormal urinary steroid excretion and subsequent breast cancer. A prospective study in the Island of Guernsey. Lancet. 1967 Mar 11;1(7489):519–522. doi: 10.1016/s0140-6736(67)92107-1. [DOI] [PubMed] [Google Scholar]
  15. CROWLEY L. G., DEMETRIOU J. A., KOTIN P., DONOVAN A. J., KUSHINSKY S. EXCRETION PATTERNS OF URINARY METABOLITES OF ESTRADIOL-4-C-14 IN POSTMENOPAUSAL WOMEN WITH BENIGN AND MALIGNANT DISEASE OF THE BREAST. Cancer Res. 1965 Apr;25:371–376. [PubMed] [Google Scholar]
  16. CROWLEY L. G., DEMETRIOU J. A., MACDONALD I., KOTIN P., KUSHINSKY S., DONOVAN A. J. Levels of exogenous estrogens in tissues in human mammary carcinoma. Surg Forum. 1962;13:103–104. [PubMed] [Google Scholar]
  17. CROWLEY L. G., MACDONALD I. Clinical trial of delautin in the treatment of advanced mammary carcinoma in postmenopausal women. Cancer. 1962 Nov-Dec;15:1218–1220. doi: 10.1002/1097-0142(196211/12)15:6<1218::aid-cncr2820150619>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  18. CROWLEY L. G., MACDONALD I. DELALUTIN AND ESTROGENS FOR THE TREATMENT OF ADVANCED MAMMARY CARCINOMA IN THE POSTMENOPAUSAL WOMAN. Cancer. 1965 Apr;18:436–446. doi: 10.1002/1097-0142(196504)18:4<436::aid-cncr2820180407>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  19. DAO T. L. Adrenalectomy for mammary cancer: A review. Q Rev Surg. 1960 Apr-Jun;17:75–95. [PubMed] [Google Scholar]
  20. DAO T. L. Cancer of the male breast treated by adrenalectomy. Surg Clin North Am. 1955 Dec;(PHILADELPHIA):1663–1667. doi: 10.1016/s0039-6109(16)34737-5. [DOI] [PubMed] [Google Scholar]
  21. DAO T. L., TAN E., BROOKS V. A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinoma. Cancer. 1961 Nov-Dec;14:1259–1265. doi: 10.1002/1097-0142(196111/12)14:6<1259::aid-cncr2820140616>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  22. DEMETRIOU J. A., CROWLEY L. G., KUSHINSKY S., DONOVAN A. J., KOTIN P., MACDONALD I. RADIOACTIVE ESTROGENS IN TISSUES OF POSTMENOPAUSAL WOMEN WITH BREAST NEOPLASMS. Cancer Res. 1964 Jun;24:926–934. [PubMed] [Google Scholar]
  23. DESHPANDE N., BULBROOK R. D., ELLIS F. G. An apparent selective accumulation of testosterone by human breast tissue. J Endocrinol. 1963 Jan;25:555–556. doi: 10.1677/joe.0.0250555. [DOI] [PubMed] [Google Scholar]
  24. DICZFALUSY E., NOTTER G., EDSMYR F., WESTMAN A. Estrogen excretion in breast cancer patients before and after ovarian irradiation and oophorectomy. J Clin Endocrinol Metab. 1959 Oct;19:1230–1244. doi: 10.1210/jcem-19-10-1230. [DOI] [PubMed] [Google Scholar]
  25. DINGMAN J. F., JESSIMAN A. G., DESPOINTES R. H., HAMMOND W. G., MATSON D. D., EMERSON K., Jr, MOORE F. D. Residual neurohypophyseal function in hypophysectomized man. N Engl J Med. 1959 May 14;260(20):997–1001. doi: 10.1056/NEJM195905142602001. [DOI] [PubMed] [Google Scholar]
  26. DOBSON L. The management of metastatic breast cancer. Surg Clin North Am. 1962 Aug;42:861–876. doi: 10.1016/s0039-6109(16)36728-7. [DOI] [PubMed] [Google Scholar]
  27. Dao T. L., Nemoto T. An evaluation of adrenalectomy and androgen in disseminated mammary carcinoma. Surg Gynecol Obstet. 1965 Dec;121(6):1257–1262. [PubMed] [Google Scholar]
  28. ELLIS F., PARKER J. R., BULBROOK R. D., DESHPANDE N. THE UPTAKE OF RADIOACTIVITY BY NORMAL AND NEOPLASTIC HUMAN BREAST TISSUES AFTER ADMINISTRATION OF TRITIATED TESTOSTERONE. Br J Surg. 1965 Jan;52:54–58. doi: 10.1002/bjs.1800520113. [DOI] [PubMed] [Google Scholar]
  29. EVANS J. P., FENGE W., KELLY W. A., HARPER P. V., Jr Transcranial yttrium90 hypophysectomy. Surg Gynecol Obstet. 1959 Apr;108(4):393–405. [PubMed] [Google Scholar]
  30. FAGER C. A. Selection of patients with metastatic breast cancer for hypophysectomy. Surg Clin North Am. 1962 Jun;42:701–707. doi: 10.1016/s0039-6109(16)36682-8. [DOI] [PubMed] [Google Scholar]
  31. FAIRGRIEVE J. SELECTIVE CRITERIA FOR SURGICAL REMOVAL OF THE ENDOCRINE GLANDS IN ADVANCED BREAST CANCER. Surg Gynecol Obstet. 1965 Feb;120:371–385. [PubMed] [Google Scholar]
  32. FURTH J. PATHOGENESIS AND CONTROL OF BREAST CANCER. Bull N Y Acad Med. 1964 Jun;40:423–431. [PMC free article] [PubMed] [Google Scholar]
  33. Falconer M. A. The Relative Values of Surgical Hypophysectomy and of Bilateral Adrenalectomy with Oophorectomy in the Treatment of Metastatic Breast Cancer. Proc R Soc Med. 1960 Aug;53(8):637–638. doi: 10.1177/003591576005300812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Fracchia A. A., Randall H. T., Farrow J. H. The results of adrenalectomy in advanced breast cancer in 500 consecutive patients. Surg Gynecol Obstet. 1967 Oct;125(4):747–756. [PubMed] [Google Scholar]
  35. Furth J. Experimental foundations and practice of hormonal control of breast cancer. Bull N Y Acad Med. 1966 Jun;42(6):509–509. [PMC free article] [PubMed] [Google Scholar]
  36. GALANTE M., FOURNIER D. J., WOOD D. A. Adrenalectomy for metastatic breast carcinoma. J Am Med Assoc. 1957 Mar 23;163(12):1011–1016. doi: 10.1001/jama.1957.02970470009003. [DOI] [PubMed] [Google Scholar]
  37. GARDNER B., THOMAS A. N., GORDAN G. S. Antitumor efficacy of prednisone and sodium liothyronine in advanced breast cancer. Cancer. 1962 Mar-Apr;15:334–337. doi: 10.1002/1097-0142(196203/04)15:2<334::aid-cncr2820150216>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  38. GLASCOCK R. F., HOEKSTRA W. G. Selective accumulation of tritium-labelled hexoestrol by the reproductive organs of immature female goats and sheep. Biochem J. 1959 Aug;72:673–682. doi: 10.1042/bj0720673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. GOLDENBERG I. S., HAYES M. A. Hormonal therapy of metastatic female breast carcinoma. I. 9 alpha-Bromo-11-ketoprogesterone. Cancer. 1959 Jul-Aug;12(4):738–740. doi: 10.1002/1097-0142(195907/08)12:4<738::aid-cncr2820120418>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  40. GORDON D., HORWITT B. N., SEGALOFF A., MURISON P. J., SCHLOSSER J. V. Hormonal therapy in cancer of the breast. III. Effect of progesterone on clinical course and hormonal excretion. Cancer. 1952 Mar;5(2):275–277. doi: 10.1002/1097-0142(195203)5:2<275::aid-cncr2820050213>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  41. HILF R., FREEMAN J. J., MICHEL I., BORMAN A. CHARACTERIZATION OF A TRANSPLANTABLE LACTATING MAMMARY TUMOR: ENDOCRINOLOGICAL, MORPHOLOGICAL, AND BIOCHEMICAL ASPECTS. Cancer Res. 1964 Jun;24:812–823. [PubMed] [Google Scholar]
  42. HILF R., MICHEL I., BELL C., FREEMAN J. J., BORMAN A. BIOCHEMICAL AND MORPHOLOGIC PROPERTIES OF A NEW LACTATING MAMMARY TUMOR LINE IN THE RAT. Cancer Res. 1965 Apr;25:286–299. [PubMed] [Google Scholar]
  43. HISAW F. L., VELARDO J. T., GOOLSBY C. M. Interaction of estrogens on uterine growth. J Clin Endocrinol Metab. 1954 Oct;14(10):1134–1143. doi: 10.1210/jcem-14-10-1134. [DOI] [PubMed] [Google Scholar]
  44. HUCK P. Artificial menopause as an adjunct to radical treatment of breast cancer. N Z Med J. 1952 Dec;51(286):364–367. [PubMed] [Google Scholar]
  45. HUGGINS C., BERGENSTAL D. M. Inhibition of human mammary and prostatic cancers by adrenalectomy. Cancer Res. 1952 Feb;12(2):134–141. [PubMed] [Google Scholar]
  46. HUGGINS C., BERGENSTAL D. M. Surgery of the adrenals. J Am Med Assoc. 1951 Sep 8;147(2):101–106. doi: 10.1001/jama.1951.03670190001001. [DOI] [PubMed] [Google Scholar]
  47. HUGGINS C., JENSEN E. V. The depression of estrone-induced uterine growth by phenolic estrogens with oxygenated functions at positions 6 or 16: the impeded estrogens. J Exp Med. 1955 Sep 1;102(3):335–346. doi: 10.1084/jem.102.3.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. HUGGINS C., Jr, TAYLOR G. W. Carcinoma of male breast. AMA Arch Surg. 1955 Feb;70(2):303–308. doi: 10.1001/archsurg.1955.01270080149025. [DOI] [PubMed] [Google Scholar]
  49. HUGGINS C., MOON R. C., MORII S. Extinction of experimental mammary cancer. I. Estradiol-17beta and progesterone. Proc Natl Acad Sci U S A. 1962 Mar 15;48:379–386. doi: 10.1073/pnas.48.3.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. HUGGINS C., YANG N. C. Induction and extinction of mammary cancer. A striking effect of hydrocarbons permits analysis of mechanisms of causes and cure of breast cancer. Science. 1962 Jul 27;137(3526):257–262. doi: 10.1126/science.137.3526.257. [DOI] [PubMed] [Google Scholar]
  51. Holleb A. I., Freeman H. P., Farrow J. H. Cancer of male breast. II. N Y State J Med. 1968 Mar 1;68(5):656–663. [PubMed] [Google Scholar]
  52. JACKSON A. W., MULDAL S., OCKEY C. H., O'CONNOR P. J. CARCINOMA OF MALE BREAST IN ASSOCIATION WITH THE KLINEFELTER SYNDROME. Br Med J. 1965 Jan 23;1(5429):223–225. doi: 10.1136/bmj.1.5429.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. JESSIMAN A. G., MATSON D. D., MOORE F. D. Hypophysectomy in the treatment of breast cancer. N Engl J Med. 1959 Dec 10;261:1199–1207. doi: 10.1056/NEJM195912102612401. [DOI] [PubMed] [Google Scholar]
  54. JESSIMAN A. G., MOORE F. D. Carcinoma of the breast; the study and treatment of the patient. N Engl J Med. 1956 May 10;254(19):900–contd. doi: 10.1056/NEJM195605102541905. [DOI] [PubMed] [Google Scholar]
  55. JONSSON U., COLSKY J., LESSNER H. E., ROATH O. S., ALPER R. G., JONES R., Jr Clinical and pharmacological observations of the effects of 9-alpha-bromo-11-beta-ketoprogesterone in patients with carcinoma of the breast. Cancer. 1959 May-Jun;12(3):509–520. doi: 10.1002/1097-0142(195905/06)12:3<509::aid-cncr2820120310>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  56. JULL L. W., SHUCKSMITH H. S., BONSER G. M. A study of urinary estrogen excretion in relation to breast cancer. J Clin Endocrinol Metab. 1963 May;23:433–444. doi: 10.1210/jcem-23-5-433. [DOI] [PubMed] [Google Scholar]
  57. KAMBOURIS A. A., SALTZSTEIN H. C., SCHEINBERG S. Bilateral adrenalectomy for advanced breast cancer. Am J Surg. 1961 Nov;102:651–656. doi: 10.1016/0002-9610(61)90614-6. [DOI] [PubMed] [Google Scholar]
  58. KAUFMAN R. J., ESCHER G. C. Rebound regression in advanced mammary carcinoma. Surg Gynecol Obstet. 1961 Nov;113:635–640. [PubMed] [Google Scholar]
  59. KENNEDY B. J. DIETHYLSTILBESTROL VERSUS TESTOSTERONE PROPIONATE THERAPY IN ADVANCED BREAST CANCER. Surg Gynecol Obstet. 1965 Jun;120:1246–1250. [PubMed] [Google Scholar]
  60. KENNEDY B. J., FORTUNY I. E. THERAPEUTIC CASTRATION IN THE TREATMENT OF ADVANCED BREAST CANCER. Cancer. 1964 Sep;17:1197–1202. doi: 10.1002/1097-0142(196409)17:9<1197::aid-cncr2820170916>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  61. KENNEDY B. J., FRENCH L. HYPOPHYSECTOMY IN ADVANCED BREAST CANCER. Am J Surg. 1965 Sep;110:411–415. doi: 10.1016/0002-9610(65)90081-4. [DOI] [PubMed] [Google Scholar]
  62. KENNEDY B. J. Massive estrogen administration in premenopausal women with metastatic breast cancer. Cancer. 1962 May-Jun;15:641–648. doi: 10.1002/1097-0142(196205/06)15:3<641::aid-cncr2820150330>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  63. KENNEDY B. J., NATHANSON I. T. Effects of intensive sex steroid hormone therapy in advanced breast cancer. J Am Med Assoc. 1953 Jul 18;152(12):1135–1141. doi: 10.1001/jama.1953.63690120004013. [DOI] [PubMed] [Google Scholar]
  64. KENNEDY B. J., TIBBETTS D. M., NATHANSON I. T., AUB J. C. Hypercalcemia, a complication of hormone therapy of advanced breast cancer. Cancer Res. 1953 Jun;13(6):445–459. [PubMed] [Google Scholar]
  65. KLOPPER A., MICHIE E. A., BROWN J. B. A method for the determination of urinary pregnanediol. J Endocrinol. 1955 May;12(3):209–219. doi: 10.1677/joe.0.0120209. [DOI] [PubMed] [Google Scholar]
  66. KOFMAN S., NAGAMANI D., BUENGER R. E., TAYLOR S. G., 3rd The use of prednisolone in the treatment of disseminated breast carcinoma. Cancer. 1958 Jan-Feb;11(1):226–232. doi: 10.1002/1097-0142(195801/02)11:1<226::aid-cncr2820110135>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  67. LANDAU R. L., EHRLICH E. N., HUGGINS C. Estradiol benzoate and progesterone in advanced human-breast cancer. A combination found effective in advanced cases. JAMA. 1962 Nov 10;182:632–636. [PubMed] [Google Scholar]
  68. LAWRENCE J. H., TOBIAS C. A., BORN J. L., McCOMBS R. K., ROBERTS J. E., ANGER H. O., LOW-BEER B. V., HUGGINS C. B. Pituitary irradiation with high-energy proton beams: a preliminary report. Cancer Res. 1958 Feb;18(2):121–134. [PubMed] [Google Scholar]
  69. LEWISON E. F., ALLEN L. W. Antecedent factors in cancer of the breast. Ann Surg. 1953 Jul;138(1):39–50. doi: 10.1097/00000658-195307000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. LUFT R., OLIVECRONA H. Experiences with hypophysectomy in man. J Neurosurg. 1953 May;10(3):301–316. doi: 10.3171/jns.1953.10.3.0301. [DOI] [PubMed] [Google Scholar]
  71. LUFT R., OLIVECRONA H. Hypophysectomy in the management of neoplastic disease. Bull N Y Acad Med. 1957 Jan;33(1):5–16. [PMC free article] [PubMed] [Google Scholar]
  72. LUFT R., OLIVECRONA H., SJOGREN B. Hypofysektomi på människa. Nord Med. 1952 Mar 14;47(11):351–354. [PubMed] [Google Scholar]
  73. MACDONALD I. Endocrine ablation in disseminated mammary carcinoma. Surg Gynecol Obstet. 1962 Aug;115:215–222. [PubMed] [Google Scholar]
  74. MANNHEIMER I. H. HYPERCALCEMIA OF BREAST CANCER; MANAGEMENT WITH CORTICOSTEROIDS. Cancer. 1965 Jun;18:679–691. doi: 10.1002/1097-0142(196506)18:6<679::aid-cncr2820180605>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  75. MARMORSTON J., CROWLEY L. G., MYERS S. M., STERN E., HOPKINS C. E. I. URINARY EXCRETION OF NEUTRAL 17-KETOSTEROIDS AND PREGNANDEIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE. Am J Obstet Gynecol. 1965 Jun 15;92:447–459. doi: 10.1016/s0002-9378(16)34834-7. [DOI] [PubMed] [Google Scholar]
  76. MARMORSTON J., CROWLEY L. G., MYERS S. M., STERN E., HOPKINS C. E. II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE. Am J Obstet Gynecol. 1965 Jun 15;92:460–467. doi: 10.1016/s0002-9378(16)34835-9. [DOI] [PubMed] [Google Scholar]
  77. MCCALISTER A., WELBOURN R. B., EDELSTYN G. J., LYONS A. R., TAYLOR A. R., GLEADHILL C. A., GORDON D. S., COLE J. O. Factors influencing response to hypophysectomy for advanced cancer of breast. Br Med J. 1961 Mar 4;1(5226):613–617. doi: 10.1136/bmj.1.5226.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Meites J., Nicoll C. S. Adenohypophysis:prolactin. Annu Rev Physiol. 1966;28:57–88. doi: 10.1146/annurev.ph.28.030166.000421. [DOI] [PubMed] [Google Scholar]
  79. Moore F. D., Woodrow S. I., Aliapoulios M. A., Wilson R. E. Carcinoma of the breast. A decade of new results with old concepts. N Engl J Med. 1967 Aug 10;277(6):293–296. doi: 10.1056/NEJM196708102770605. [DOI] [PubMed] [Google Scholar]
  80. Moore F. D., Woodrow S. I., Aliapoulios M. A., Wilson R. E. Carcinoma of the breast. A decade of new results with old concepts. N Engl J Med. 1967 Aug 24;277(8):411–416. doi: 10.1056/NEJM196708242770807. [DOI] [PubMed] [Google Scholar]
  81. Muggia F. M., Cassieth P. A., Ochoa M., Jr, Flatow F. A., Gellhorn A., Hyman G. A. Treatment of breast cancer with medroxyprogesterone acetate. Ann Intern Med. 1968 Feb;68(2):328–337. doi: 10.7326/0003-4819-68-2-328. [DOI] [PubMed] [Google Scholar]
  82. Mye G. L., Jr, Neal W., Jr Bilateral adrenalectomy for advanced mammary cancer: 9-year review of 84 cases. Am Surg. 1965 Oct;31(10):621–624. [PubMed] [Google Scholar]
  83. NATHANSON I. T., KELLEY R. M. Hormonal treatment of cancer. N Engl J Med. 1952 Jan 24;246(4):135–contd. doi: 10.1056/NEJM195201242460405. [DOI] [PubMed] [Google Scholar]
  84. NELSEN T. S., DRAGSTEDT L. R. Adrenalectomy and oophorectomy for breast cancer. JAMA. 1961 Feb 4;175:379–383. doi: 10.1001/jama.1961.03040050035008. [DOI] [PubMed] [Google Scholar]
  85. NISSEN-MEYER R. PROPHYLACTIC ENDOCRINE TREATMENT IN CARCINOMA OF THE BREAST. Clin Radiol. 1964 Apr;15:152–160. doi: 10.1016/s0009-9260(64)80031-3. [DOI] [PubMed] [Google Scholar]
  86. NISSEN-MEYER R., SANNER T. THE EXCRETION OF OESTRONE, PREGNANEDIOL AND PREGNANETRIOL IN BREAST CANCER PATIENTS. I. EXCRETION AFTER SPONTANEOUS MENOPAUSE. Acta Endocrinol (Copenh) 1963 Nov;44:325–333. doi: 10.1530/acta.0.0440325. [DOI] [PubMed] [Google Scholar]
  87. PALMER J. D., HELSTROM J. The use of urinary estrogen estimations as a means of predicting response to oophorectomy and adrenalectomy in breast cancer. Can J Surg. 1962 Apr;5:180–186. [PubMed] [Google Scholar]
  88. PEARSON O. H., LI M. C., MACLEAN J. P., LIPSETT M. B., WEST C. D. The use of hydrocortisone in cancer. Ann N Y Acad Sci. 1955 May 27;61(2):393–396. doi: 10.1111/j.1749-6632.1955.tb42489.x. [DOI] [PubMed] [Google Scholar]
  89. PEARSON O. H., RAY B. S. Hypophysectomy in the treatment of metastatic mammary cancer. Am J Surg. 1960 Apr;99:544–552. doi: 10.1016/0002-9610(60)90149-5. [DOI] [PubMed] [Google Scholar]
  91. REES E. D., HUGGINS C. Steroid influences on respiration, glycolysis, and levels of pyridine nucleotide-linked dehydrogenases of experimental mammary cancers. Cancer Res. 1960 Jul;20:963–971. [PubMed] [Google Scholar]
  92. ROSENBERG M. F., UHLMANN E. M. Prophylactic castration in carcinoma of the breast. AMA Arch Surg. 1959 Mar;78(3):376–379. doi: 10.1001/archsurg.1959.04320030020004. [DOI] [PubMed] [Google Scholar]
  93. Ray B. S. Current cancer concepts. Hypophysectomy as palliative treatment. JAMA. 1967 Jun 12;200(11):974–975. [PubMed] [Google Scholar]
  94. SANDISON A. T. MALE BREAST CANCER IN KLINEFELTER'S SYNDROME. Br Med J. 1965 Feb 20;1(5433):521–522. doi: 10.1136/bmj.1.5433.521-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. SAUNDERS F. J. EFFECTS OF STEROIDS ON PITUITARY GONADOTROPIN AND FERTILITY. Recent Prog Horm Res. 1964;20:395–434. [PubMed] [Google Scholar]
  96. SEGAL S. J., WICKS A. E. Time and dose relationships in estriol-estradiol interaction. Proc Soc Exp Biol Med. 1956 Nov;93(2):270–273. doi: 10.3181/00379727-93-22729. [DOI] [PubMed] [Google Scholar]
  97. SHERLOCK P., HARTMANN W. H. Adrenal steroids and the pattern of metastases of breast cancer. JAMA. 1962 Jul 28;181:313–317. doi: 10.1001/jama.1962.03050300033007. [DOI] [PubMed] [Google Scholar]
  98. SWYER G. I., LEE A. E., MASTERTON J. P. Oestrogen excretion of patients with breast cancer. Br Med J. 1961 Mar 4;1(5226):617–619. doi: 10.1136/bmj.1.5226.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Stoll B. A. Corticosteroids in Therapy of Advanced Mammary Cancer. Br Med J. 1963 Jul 27;2(5351):210–214. doi: 10.1136/bmj.2.5351.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Stoll B. A. Effect of Lyndiol, an oral contraceptive, on breast cancer. Br Med J. 1967 Jan 21;1(5533):150–153. doi: 10.1136/bmj.1.5533.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Stoll B. A. Progestin therapy of breast cancer: comparison of agents. Br Med J. 1967 Aug 5;3(5561):338–341. doi: 10.1136/bmj.3.5561.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. TALALAY P. THE SCIENTIFIC CONTRIBUTIONS OF CHARLES BRENTON HUGGINS. JAMA. 1965 Jun 28;192:1137–1140. doi: 10.1001/jama.1965.03080260025007. [DOI] [PubMed] [Google Scholar]
  103. TAYLOR S. G., 3rd Endocrine ablation in disseminated mammary carcinoma. Surg Gynecol Obstet. 1962 Oct;115:443–448. [PubMed] [Google Scholar]
  104. TREVES N. An evaluation of prophylactic castration in the treatment of mammary carcinoma: an analysis of 152 patients. Cancer. 1957 Mar-Apr;10(2):393–407. doi: 10.1002/1097-0142(195703/04)10:2<393::aid-cncr2820100223>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  105. TREVES N. The treatment of cancer, especially inoperable cancer, of the male breast by ablative surgery (orchiectomy, adrenalec tomy, and hypophysectomy) and hormone therapy (estrogens and corticosteroids); an analysis of 42 patients. Cancer. 1959 Jul-Aug;12(4):820–832. doi: 10.1002/1097-0142(195907/08)12:4<820::aid-cncr2820120427>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  106. VILLEE C. A., HAGERMAN D. D. Compounds with antiestrogenic activity in vitro. Endocrinology. 1957 Apr;60(4):552–558. doi: 10.1210/endo-60-4-552. [DOI] [PubMed] [Google Scholar]
  107. VOLKMAN A., CROCKER D. W., JESSIMAN A. G., EMERSON E., Jr A clinicopathologic correlation of the effect of hypophysectomy in seven female patients with advanced carcinoma of the breast. Am J Surg. 1962 Apr;103:415–423. doi: 10.1016/0002-9610(62)90145-9. [DOI] [PubMed] [Google Scholar]
  108. WHITAKER B. L. Plasma beta-glucuronidase as an index of hormone dependency of breast tumours. Br J Cancer. 1961 Dec;15:868–884. doi: 10.1038/bjc.1961.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. WOOLF C. M. Investigations on genetic aspects of carcinoma of the stomach and breast. Publ Public Health Univ Calif. 1955;2(4):265–349. [PubMed] [Google Scholar]
  110. Zervas N. T., Gordy P. D. Radiofrequency hypophysectomy for metastatic breast and prostatic carcinoma. Surg Clin North Am. 1967 Oct;47(5):1279–1285. doi: 10.1016/s0039-6109(16)38347-5. [DOI] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES